User profiles for Bora Peynircioglu

Bora Peynircioglu

Hacettepe university
Verified email at hacettepe.edu.tr
Cited by 2028

[PDF][PDF] Subcutaneous venous port implantation in adult patients: a single center experience

BE Çil, M Canyigit, B Peynircioglu, T Hazirolan… - Diagnostic and …, 2006 - Citeseer
Materials and methods This study included 472 patients from our database who were treated
between January 2001 and November 2005. In total, 476 venous ports were placed in 221 (…

Clinical application of trans-arterial radioembolization in hepatic malignancies in Europe: first results from the prospective multicentre observational study CIRSE …

…, G Munneke, O Pellerin, B Peynircioglu… - Cardiovascular and …, 2021 - Springer
Purpose To address the lack of prospective data on the real-life clinical application of trans-arterial
radioembolization (TARE) in Europe, the Cardiovascular and Interventional …

Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma

O Öcal, M Ingrisch, MR Ümütlü, B Peynircioglu… - British journal of …, 2022 - nature.com
Aims To investigate the prognostic value of baseline imaging features for overall survival (OS)
and liver decompensation (LD) in patients with hepatocellular carcinoma (HCC). Design …

Liver function after combined selective internal radiation therapy or sorafenib monotherapy in advanced hepatocellular carcinoma

…, OM van Delden, H Amthauer, B Peynircioglu… - Journal of …, 2021 - Elsevier
Background & Aims SORAMIC is a previously published randomised controlled trial assessing
survival in patients with advanced hepatocellular carcinoma who received sorafenib with …

Factors affecting the response to Y-90 microsphere therapy in the cholangiocarcinoma patients

…, MF Bozkurt, S Kılıçkap, B Peynircioğlu… - La radiologia …, 2021 - Springer
Objective The aim of this study was to assess the early therapy response in patients with
unresectable CCA who received Y-90 microsphere therapy for CCA and define the factors …

Predictive factors for adverse event outcomes after transarterial radioembolization with yttrium-90 resin microspheres in Europe: results from the prospective …

…, F Kolligs, G Munneke, B Peynircioglu… - Cardiovascular and …, 2023 - Springer
Background Using data collected in the prospective observational study CIRSE Registry for
SIR-Spheres Therapy, the present study aimed at identifying predictors of adverse events (…

Renal artery pseudoaneurysm: complication of minimally invasive kidney surgery

K Inci, B Cil, S Yazici, B Peynircioglu, B Tan… - Journal of …, 2010 - liebertpub.com
Purpose: We retrospectively reviewed the charts of patients with renal artery pseudoaneurysms
(RAPs) to document their clinical presentation, surgical background, and outcome. …

[PDF][PDF] Peripheral vascular applications of the Amplatzer® vascular plug

B Çil, B Peynircioglu, M Canyigit… - Diagnostic and …, 2008 - cms.dirjournal.org
Materials and methods Between May 2005 and October 2006, 12 patients (10 male, 2
female) aged between 24 and 80 years (mean age, 55 years) who underwent percutaneous …

Short-term safety and quality of life outcomes following radioembolization in primary and secondary liver tumours: a multi-centre analysis of 200 patients in France

…, JP Pelage, O Pellerin, B Peynircioglu… - Cardiovascular and …, 2021 - Springer
Purpose Radioembolization has emerged as a treatment modality for patients with primary
and secondary liver tumours. This observational study CIRT-FR (CIRSE Registry for SIR-…

Giant renal artery pseudoaneurysm caused by rupture of renal angiomyolipoma following pregnancy: endovascular treatment and review of the literature

…, S Vesnic, B Cil, B Peynircioglu - Saudi Journal of Kidney …, 2014 - journals.lww.com
Renal angiomyolipoma is a hamartomatous, benign tumor composed of blood vessels, fatty
tissue and smooth muscle cells, and is often detected incidentally. It can also be associated …